Invasive Fungal Infection

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Registry of Patients Treated With Systemic Mold-Active Triazoles

Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients

Association of Plasma Transfusions and Invasive Fungal Infection

An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM

Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL

Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates

Pharmacokinetics of Micafungin in Patients Intensive Care Unit

Pharmacologic Optimization of Voriconazole

Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia

Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)

Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit

Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

Voriconazole Plasma Level in Intensive Care Unit (ICU) Patients

Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection

Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT